Mumbai, November 28, 2018: Cipla Limited (BSE: 500087, NSE: CIPLA) today announced its unaudited consolidated financial results for quarter ended September…
New Delhi, November 24, 2018: Launched the first-ever AI-powered Cardiovascular Disease Risk Score API (Application Program Interface), designed specifically to…
Full year 2018: Increase of EBITDA pre exceptionals now expected at the upper end of the guidance of five to…
CPhI Middle East & Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government reforms to…
Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue…
New Delhi, August 12, 2018: Q1FY19 Standalone Revenues grew 16% to Rs.19,104 million compared to Rs.16,504 million in Q1FY18, aided…
New Delhi, August 12, 2018: Pharma major Glenmark Pharmaceuticals on Friday reported consolidated net profit of ₹232.99 crore in the first…
New Delhi, August 12, 2018: India’s pharmaceutical exports grew merely 3 percent to $17.3 billion in 2017-18 due to increasing regulatory…
New Delhi, August 12, 2018: Net sales during the quarter fell 4.2 percent to $154.6 million compared to $161.3 million…
Mumbai, August 08, 2018: Cipla Limited (BSE: 500087, NSE: CIPLA) today announced its unaudited consolidated financial results for quarter ended…